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Aim To assess the usefulness of a DNA-based method for 
identifying mushroom species for application in forensic 
laboratory practice.
Methods Two hundred twenty-one samples of clinical fo-
rensic material (dried mushrooms, food remains, stomach 
contents, feces, etc) were analyzed. ITS2 region of nuclear 
ribosomal DNA (nrDNA) was sequenced and the sequen-
ces were compared with reference sequences collected 
from the National Center for Biotechnology Information 
gene bank (GenBank). Sporological identification of mush-
rooms was also performed for 57 samples of clinical ma-
terial.
Results Of 221 samples, positive sequencing results were 
obtained for 152 (69%). The highest percentage of posi-
tive results was obtained for samples of dried mushrooms 
(96%) and food remains (91%). Comparison with GenBank 
sequences enabled identification of all samples at least at 
the genus level. Most samples (90%) were identified at the 
level of species or a group of closely related species. Sporo-
logical and molecular identification were consistent at the 
level of species or genus for 30% of analyzed samples.
Conclusion Molecular analysis identified a larger number 
of species than sporological method. It proved to be suit-
able for analysis of evidential material (dried hallucinogen-
ic mushrooms) in forensic genetic laboratories as well as 
to complement classical methods in the analysis of clinical 
material.
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Gathering and eating wild mushrooms is an important 
part of culinary culture in Poland. The popularity of this 
pastime, coupled with an inability of consumers to distin-
guish edible from inedible species, results in many cases 
of poisoning every year (1-5). Poisonous mushrooms can 
be divided into 9 basic groups based on their type of to-
xic action (6). Poisoning by gastro-enterotoxic mushrooms, 
which causes irritation of the gastrointestinal tract (nausea, 
vomiting, diarrhea), constitutes a relatively minor threat to 
life and health. The most serious poisonings are caused by 
mushrooms with cytotoxic-hepatotoxic action, eg, Ama­
nita phalloides and the similar species, Amanita verna, and 
Amanita virosa, which are often confused with edible spe-
cies from the genera Russula, Agaricus, and Macrolepiota. 
Besides Amanita, there are highly toxic species belon-
ging to other genera (eg, Galerina marginata, Galerina au­
tumnalis, and Lepiota helveola). In recent years, there has 
been an increased interest in hallucinogenic mushrooms 
due to easy access to this source of narcotic substances 
(7). Possession, sale, and purchase of mushrooms contain-
ing narcotic substances is a crime under current law in 
many countries, including Poland. Thus, identification of 
mushrooms containing prohibited active substances is of 
key significance for judicial proceedings. Currently, there 
are over 200 known species of mushrooms with narcot-
ic properties. The majority of these are species of Psilocy­
be, Gymnopilus, and Paneolus, as well as some species of 
toadstools, eg, Amanita muscaria and Amanita pantherina. 
Some species from the genera Conocybe, Inocybe, Stro­
pharia, Pluteus, Hypholoma, and Panaeolina (8,9) are also 
suspected of containing hallucinogenic substances. The 
most important psychotropic substances in hallucino-
genic mushrooms are psilocybin, psilocin, and baeocys-
tin (8,10). There are occasional fatal cases of poisoning by 
mushrooms from the genus Galerina, mistaken for hallu-
cinogenic mushrooms from the genus Psilocybe. Similar 
mistakes have been made with mushrooms of the genus 
Conocybe, eg, Conocybe blatteria, which can be confused 
with Psilocybe semilanceata (11).
In mushroom poisonings, the source of the toxic substance 
is usually identified using morphological (mainly sporolo-
gical) and biochemical (toxicological) analysis. Clinical ma-
terial such as vomit, gastric contents, stool samples, and 
remnants of uneaten food often contain entire fragments 
of sporocarps, which can be examined macroscopically 
and microscopically. This kind of analysis often enables 
identification of fungal material at the genus level. Sporo-
logical analysis, based on microscopic examination of the 
clinical material, determines the presence of spores and 
identifies them through comparison with standard fungal 
spores. In doubtful cases, the result requires verification by 
2 or 3 competent laboratory workers (12).
Methods applied in toxicological analysis include high-
performance liquid chromatography with diode array de-
tection, gas chromatography with mass spectrometry, and 
liquid chromatography with mass detection (13,14). These 
methods enable not only identification of a specific active 
substance, but also quantitative analysis, provided appro-
priate standards are used. A difficulty associated with in-
strumental methods is the need to extract toxic substan-
ces from biological material. For amanitine, the extraction 
method requires the use of immunoaffinity techniques us-
ing specific antibodies (15).
Fungal species identification based on genetic analysis is a 
promising alternative to morphological and physicochemic-
al studies. Several polymerase chain reaction (PCR)-based 
methods of DNA analysis have been employed in species 
identification, eg, random amplification of polymorphic 
DNA (RAPD), amplified fragment length polymorphism 
(AFLP), restriction fragment length polymorphism (RFLP), 
and real-time PCR and DNA sequencing. Some of these 
methods, such as RAPD and AFLP methods, analyze the 
whole genome and are applied in the identification of poly-
morphisms and determination of genetic distance between 
species, but are not suitable for identification of closely-re-
lated species (16,17). Other methods, eg, real-time PCR and 
DNA sequencing, are based on the amplification of DNA-
fragments of taxonomic relevance. In animals, the region 
encoding the enzyme cytochrome oxidase (COI) has been 
proposed as a target region in DNA barcoding, enabling 
identification of 95% of species (18,19), but in fungi, this re-
gion enables identification of only 20%-70% of species (19). 
In fungi, the most important target region is nuclear DNA 
encoding ribosomal RNA (nrDNA), arranged in the form of 
tandem repeats. The number of copies of nrDNA genes in 
mushrooms varies from 60 to 220, depending on the spe-
cies. Fragments encoding ribosomal RNA are separated by 
non-coding fragments, which are removed after the tran-
scription phase. These so-called internal transcribed spac-
ers (ITS1 and ITS2) and non-transcribed intergenic spacers 
(IGS) are characterized by the presence of polymorphisms 
of length and sequence, which make them highly useful for 
species identification.
There are primers serving in the amplification of both ITS 
regions, including the 5,8S coding region, as well as spe-
cies-specific primers targeting the ITS (20,21). Lee et al 
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(22) showed that hallucinogenic mushrooms from the gen-
era Panaeolus and Psilocybe can be differentiated on the ba-
sis of differences in the lengths of ITS1 PCR products. How-
ever, for some species, sequencing of the studied fragments 
is ne cessary. Knowing the entire sequence of the studied re-
gion also enables better differentiation of analyzed samples. 
As numerous studies have shown (22-26), analysis of the se-
quences of ITS regions is useful for creating molecular sys-
tematics at the species level, and even for defining intraspe-
cific geographic differentiation. Furthermore, existence of 
numerous copies of these regions enables their amplifica-
tion even in considerably degraded material, which makes 
them very attractive for forensic testing (22). Studies con-
ducted on the polymorphism of the ITS region, encompass-
ing mushrooms belonging to many taxa, have shown the 
usefulness of these regions as a basic universal marker in the 
Fungi kingdom (27-29). The aim of this study was to develop, 
optimize, and assess the usefulness of a molecular method 
based on sequencing of the ITS region of nrDNA in the fo-
rensic and clinical identification of mushrooms. Our research 
is the first with such a large number of samples of clinical 
and forensic material originating from Central Europe.
MATeriAl And MeThOdS
Analyzed material
The study was carried out in the period 2011-2013. We used 
clinical forensic samples containing fragments of mush-
rooms, such as vomit, gastric contents, food remains, and 
shredded dried mushrooms. Samples of clinical material, as 
well as some food remains, were supplied by the Institute of 
Occupational Medicine and Environmental Health in Sos-
nowiec. Some of the dried mushrooms came from the De-
partment of Toxicology of the Institute of Forensic Research 
(5 samples). We prepared the remaining samples of dried 
mushrooms and food ourselves (by subjecting sporocarps 
of fungi of various edible, inedible, and poisonous species 
to heat treatment or drying). A total of 221 samples were 
studied, including 132 samples of clinical material, 65 dish 
samples, and 24 samples of dried mushrooms. Clinical ma-
terial consisted of gastrointestinal content and feces, with 
and without visible mushroom fragments. Bits that looked 
like fragments of fruiting bodies (sporocarps) of mushrooms 
were analyzed and when no obvious fragments were pre-
sent (eg, in some samples of stomach contents obtained 
by gastric lavage), all the solid material obtained following 
centrifugation of the sample was collected. Samples thus 
obtained were twice rinsed in 70% ethanol and deion-
ized water prior to DNA extraction.
dnA extraction and amplification
Based on a preliminary study on various DNA extraction 
methods (data not shown), we used the magnetic method, 
employing a BioRobot M48 robotic workstation (Qiagen, 
Hilden, Germany) and compatible MagAttract reagent kits 
(Qiagen) for DNA isolation, as this proved the most efficient. 
The procedure followed the protocols provided by Qiagen 
(http://www.qiagen.com/pl/products/catalog/sample-
technologies/dna-sample-technologies/genomic-dna/
magattract-dna-mini-m48-kit/#resources). This method, as 
well as methods employing similar reagent kits, are rou-
tinely used in forensic laboratory practice in the process of 
DNA isolation from biological traces (30-33).
PCR reactions were performed using HotStarTaq Mas-
ter Mix Kit (Qiagen) in an ABI 9700 thermocycler (Ap-
plied Biosystems, Foster City, USA). Primers complemen-
tary to the ITS1 region (primers ITS1F and ITS2) and ITS2 
region (primers ITS3 and ITS4) were initially used for am-
plification (20,21). Analysis of samples originating from 
gastrointestinal contents yielded either sequences of sac 
fungi (Ascomycota) colonizing the gastrointestinal tract 
(most frequently Candida spp) or a mixture of products 
unsuitable for further analysis. The vast majority of ed-
ible mushrooms and poisonous mushrooms belong to 
the phylum Basidiomycota. Accordingly, pairs of pri mers 
ITS3 (5’GCATCGATGAAGAACGCAGC3’) (20) and ITS4B 
(5’CAGGAGACTTGTACACGGTCCA3’) (21), which amplify 
the ITS2 region, along with a fragment of the region en-
coding 28S nrDNA, were finally used for DNA amplification 
from clinical forensic samples. Primer ITS4B (Basidiomyco-
ta-specific) was applied in order to obtain an amplification 
product of Basidiomycota DNA exclusively. PCR reactions 
were carried out using the following thermal profile: 15 
min at 95°C, followed by 35 cycles of 30 sec at 95°C, 30 sec 
at 58°C, 1 minute at 72°C, and termination 10 min at 72°C. 
In order to check the efficiency of amplification, electro-
phoretic separation was performed with a QIAxcel appara-
tus for automated capillary electrophoresis using a QIAxcel 
DNA Screening Kit (Qiagen). For purification of amplifica-
tion products, the enzymatic method was applied, using 
reagents Exonuclease I (ExoI) and Thermo Scientific FastAP 
Thermosensitive Alkaline Phosphatase (FastAP) (Thermo 
Scientific, Waltham, USA).
dnA sequencing and sequence analysis
Sequencing reactions were carried out in both directions, 
using amplification primers and a BigDye Terminator Cycle 
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Sequencing kit, v. 3.1 (Applied Biosystems), according to 
the manufacturer’s recommendations (25 cycles of 10 min 
at 96°C, 5 sec at 55°C, and 2 min at 60°C). The products 
were purified using ExTerminator 96 plates (A&A Biotech-
nology, Gdynia, Poland) and subjected to electrophoretic 
separation, with the application of ABI Prism 3130xl ge-
netic analyzer (Applied Biosystems) (gel POP 7, capillary 36 
cm). The obtained sequences were aligned using Clustal W, 
v. 2.0.12 (34) contained in BioEdit, v. 7.0.8.0 (35), and DNA 
Baser Sequence Assembler, v. 4.10.1.13 (36).
Comparison with the nCBi database
For the purpose of species identification, the obtained se-
quences were compared with sequences available in the 
National Center for Biotechnology Information (NCBI) in-
ternet database (GenBank), using the BLAST program (37). 
Depending on the level of consistency with the reference 
sequences, six identification levels (Table 1) were deter-
mined (38).
Toxicological analysis
Results of toxicological analysis were available for 5 sam-
ples of dried mushrooms. This analysis was carried out 
using gas chromatography methods coupled with mass 
spectrometry and high-performance liquid chromato-
graphy, aimed at determining the content of psychoactive 
substances (data obtained from the Department of Toxi-
cology of the Institute of Forensic Research).
Sporological analysis
Results of sporological analysis were available for 57 clinical 
samples (data obtained from the Institute of Occupational 
Medicine and Environmental Health in Sosnowiec). Micro-
scopic analysis included three steps (12):
1. Degreasing, concentrating, and dissolving the analyzed 
material.
2. Chemical microreactions with Melzer’s reagent, Sudan 
III, and 10% HCl.
3. Microscopic comparison with standard fungal spores 
from a collection acquired by the Department of Labora-
tory Diagnostics, Institute of Occupational Medicine and 
Environmental Health in Sosnowiec.
reSulTS
results of molecular analysis
Of 221 samples, positive amplification results were ob-
tained for 192 (87%). The percentage of successfully am-
plified samples depended on the type of studied material, 
ranging from 75% (15 out of 20 samples) for gastrointes-
tinal contents with no visible fragments of mushrooms 
to 100% (24 samples) for dried mushrooms (Table 2). 
Among positively amplified samples, the lowest percen-
tage of sequences suitable for further analysis was ob-
tained for samples of feces (35%, 6 out of 17 samples) and 
the highest for food remains (91%, 59 out of 65 samples) 
and dried mushrooms (96%, 23 out of 24 samples) (Table 
2). For highly processed material, we obtained mixtures 
of sequencing products that were unsuitable for inter-
pretation, constituting from 27% to 58% (gastrointestinal 
content and feces, respectively) of the positively ampli-
fied samples.
Comparison with the nCBi database
Comparison with the sequences stored in the NCBI 
gene bank (GenBank) enabled us to classify 90% of 
samples for which sequences were obtained at the 
TABle 1. levels of sample identification determined for the present study
level of identification level of sequence consistency with national Center for Biotechnology information gene bank database
Species Maximal consistency 97% or greater, with reference sequences of single species.
Group of species Maximal consistency 97% or greater, with reference sequences of several different species that are closely 
related to each other.
Genus 1. Maximal consistency below 97%, with reference sequences of one species or several species belonging to 
the same genus.
2. Maximal consistency 97% or greater, with reference sequences of several different species that are not 
closely related to each other, but belong to the same genus.
Group of genera Sequences of the highest consistency belong to members of several genera that are closely related to each 
other.
Family Sequences of the highest consistency belong to members of several genera of to the same family.
No identification Sequences of the highest consistency belong to members of different families.
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level of species or a group of closely related species. In 
10% of samples, identification was possible at the genus 
level (Table 3).
results of toxicological and sporological analysis
In one of the studied samples for which toxicological data 
were available, the presence of psilocin was ascertained. 
Genetic analysis identified this sample (S017) as belong-
ing to the species Psilocybe semilanceata. In the 4 remain-
ing samples, the presence of psilocin was not ascertained. 
However, genetic analysis identified 3 samples (S072, S073, 
and S074) as Psilocybe cubensis and one sample (S016) as 
a specimen of Agrocybe pediades (Supplementary Table). 
Fungal spores were identified in 76% of microscopically 
examined samples and their analysis enabled us to identify 
over 50% of samples at the species level (Table 3).
Comparison of the molecular and sporological method
For 30% of microscopically examined samples, sporologi-
cal and molecular identification was consistent at least at 
the genus level, whereas for 26% of samples there was no 
consistency. For most of the samples with negative sporo-
logical identification, the material was identified by mo-
lecular methods (Table 4). Sporological analysis revealed 
the presence of fungi that had not been identified by mo-
lecular methods in the following samples (Supplementary 
Table): sample S154 (spores of Mycena sp and Coprinus sp); 
sample S053 (spores of Amanita sp); sample S200 (spores 
of Macrolepiota sp).
diSCuSSiOn
The study found that the molecular method for fungi spe-
cies identification was useful for forensic and clinical pur-
poses. The method yielded a positive result despite the 
fact that fruiting bodies of fungi were processed to a high 
degree (and hence DNA was degraded). The best results 
were obtained for dried mushrooms and food leftovers. 
However, this method has certain limitations. In clinical 
samples, there is the problem of DNA mixtures, resulting 
in unreadable sequencing results. The occurrence of mix-
tures of sequences may be linked to the presence of other 
species of fungi in the gastrointestinal tract or to contami-
nation by molds during sample storage prior to analysis. 
Since most fungi colonizing the human digestive tract (eg, 
Candida albicans), as well as molds, belong to the phylum 
Ascomycota, and a great majority of edible and poisonous 
mushrooms belong to Basidiomycota, this problem can be 
partially solved by applying primers specific for the latter 
(eg, ITS4B). However, this limits the analysis to the ITS2 re-
gion due to a lack of primers that are both specific for Ba-













Feces with visible fragments of mushrooms 13  12 (92) 5 7 38
Feces without visible fragments 4   2 (50) 1 1 25
Gastrointestinal content with visible mushroom fragments 95  79 (83) 53 26 56
Gastrointestinal content without visible fragments 20  15 (75) 11 4 55
Food remains 65  60 (92) 59 1 91
Dried mushrooms 24  24 (100) 23 1 96
Total 221 192 (87) 152 40 69







Species 129 (85) 30 (53)
Group of species   7 (5)  0 (0)
Genus/group of genera  16 (10)  8 (14)
Family   0 (0)  5 (9)
No identification   0 (0) 14 (25)
Total 152 (100) 57 (100)





The same species  8 (14)
The same group of species  0 (0)
The same genus/group of genera  9 (16)
The same family  5 (9)
No concordance 15 (26)
No spores present/Molecular identification negative  1 (2)
No spores present/Molecular identification positive 13 (23)
Molecular identification negative/Sporological 
identification positive
 6 (11)
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sidiomycota and enable amplification of the ITS1 region. 
Application of a primer specific for Basidiomycota results 
in the impossibility of identifying poisonous mushrooms 
belonging to Ascomycota (eg, members of the genus Gy­
romitra). On the other hand, the possible (though rare) 
presence of microscopic fungi belonging to Basidiomy-
cota cannot be eliminated when using such an amplifica-
tion primer. One example might be a sequence of a mem-
ber of the genus Kwoniella found in the material collected 
from the gastrointestinal contents of patient No. 55. Genus 
Kwoniella encompasses the five currently known species of 
fungi from the order Tremellales, which are closely related 
to the genus Filobasidiella and consist of saprobion tic, mi-
croscopic fungi that do not form fruiting bodies (39-43). 
The presence of one of the Kwoniella species was ascer-
tained in the gastrointestinal tract (43). There is also the 
problem of mixtures of various species of mushrooms con-
sumed together, which are often impossible to be sepa-
rated due to significant fragmentation and degradation of 
fungal material in gastrointestinal contents.
One solution to the problem of mixtures might be the ap-
plication of next generation sequencing. However, this 
method is still too costly for routine forensic and clinical 
analyses. Other possible solutions include the use of spe-
cies-specific primers for amplification or methods based 
on specific oligonucleotide probes. To identify the hallu-
cinogenic mushroom Psilocybe semilanceata, Adamczyk et 
al (44) applied PCR primers enabling specific amplification 
of the ITS1 region of this species. Harper et al (45) designed 
a method using macroarrays with oligonucleotide probes 
based on species-specific fragments of ITS region. This 
method rapidly identifies the most toxic mushrooms from 
the genus Amanita. Harper et al showed that this method 
can be used to distinguish individual species in samples 
containing mixtures of mushroom fragments from differ-
ent species. However, in some cases false positive and false 
negative reactions occurred. This method, though fast and 
relatively inexpensive, requires development of oligonu-
cleotide probes for additional species of toxic and hallu-
cinogenic mushrooms. Thus, to obtain information on the 
present polymorphism needed to create oligonucleotide 
probes it is necessary to sequence the ITS region.
The most important stage of our method is the compar-
ison of obtained sequences with reference sequences 
available in databases. This approach has been applied in 
studies on hallucinogenic mushrooms present on the Jap-
anese market (7). The obtained sequences were matched 
using BLAST software with sequences of ITS regions in sev-
eral databases (GenBank, EMBL, and DDBJ). This enabled 
species identification of all samples (7). The limitation of 
this approach is that publicly available databases may con-
tain mistakes resulting from incorrect species identification 
or low quality of sequences (23,46,47). For example, in our 
study a high degree of consistency was found between all 
sample sequences correctly identified as Amanita muscaria 
and an individual sequence of Amanita gemmata from the 
NCBI database (Supplementary Table, samples: S131, S186-
S188, S195, S197, S202-S205, S209, S217). One solution to 
this problem might be to create reference databa ses con-
taining material from a defined geographical region that 
has been precisely and reliably identified.
Our research showed that sequencing of the ITS2 fragment 
was sufficient in most cases and that it correctly identified 
the most frequent causes of mushroom poisonings, as well 
as the most common hallucinogenic mushrooms. Among 
the 152 studied samples for which correct sequences of 
the ITS region were obtained, the great majority of poison-
ous and hallucinogenic mushrooms were identified at the 
species level (Supplementary Table). Identification prob-
lems (ie, identification only at the genus level) were limited 
to certain members of the genera Russula (samples S136, 
S137, S166, S167, and S192) and Cortinarius (sample S042). 
Within Russula, however, there are no highly poisonous 
species, only those characterized by gastroenterotoxic ac-
tion. Genus Cortinarius is more problematic, as it includes 
highly poisonous species. Species identification is also ne-
cessary in the case of hallucinogenic mushrooms from the 
genus Psilocybe, as it includes both species that produce 
toxic substances and species that are not toxic (8,9,11,48).
Other studies show that the high degree of polymorphism 
of sequences of the ITS region may lead to ambiguous 
identifications of closely related species (49,50). Nugent 
and Saville (51) also used sequencing of the region en-
coding the nuclear large ribosomal subunit of rRNA (nLSU 
rRNA) with a lower degree of polymorphism, which highly 
reliably differentiated closely related species of hallucino-
genic mushrooms from North America.
For certain groups of fungi, additional sequencing of the 
nLSU region may not suffice for correct species differentia-
tion. In some species of genus Cortinarius that are difficult 
to differentiate using the ITS and nLSU regions, full iden-
tification was performed only by analysis of sequences 
of genes encoding RNA polymerase (RPB1 and RPB2) in 
combination with sequences of the ITS region (50). Ac-
cordingly, when identification based on analysis of 
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the ITS region (eg, of a member of the genus Cortinarius) is 
doubtful, it would be advisable to use additional markers 
(eg, LSU, RPB1, and RPB2). This, however, may be difficult, 
as sequences of these regions for many species are often 
unavailable in refe rence databases.
Kallifatidis et al (52) used a method based on the analy-
sis of fluorescent random amplified microsatelites to dis-
tinguish between closely related species that cannot be 
differentiated using sequencing of the ITS region (eg, 
Psilocybe moravica, P. serbica, and P. bohemica). Using this 
method, a high degree of intraspecific variation can also 
be observed. The authors examined 20 species belonging 
to the Amanita and Psilocybe genera. Application of this 
method in forensic or clinical practice requires develop-
ment of a reference database including the most common 
hallucinogenic and other toxic mushrooms. Also, the anal-
ysis of clinical samples may be significantly complicated 
by the presence of gastrointestinal microbiota. Our results 
showed that molecular analysis identified a larger num-
ber of mushroom species in clinical forensic samples than 
sporological and toxicological methods. In some samples, 
sporological analysis revealed the presence of species not 
identified by molecular method. However, genetic identifi-
cation significantly increased the number of identified spe-
cies (eg, in samples taken from patients No. 12, 13, 56, 65, 
67, 75, and 81, Supplementary Table).
Sporological methods were less precise than molecular 
methods, due to the similarity of spores of various genera/
species of mushrooms (eg, in the case of patients No. 12 – 
Cortinarius/Inocybe, 22 – Lactarius/Russula, 53 – Stropharia/
Macrolepiota, 67 – Chlorophyllum/Macrolepiota) or the im-
possibility to identify spores more specifically than at the 
genus level. Morphological features of spores are some-
times similar in poisonous and non-toxic species (53). In 
a microscopic preparation, Amanita spores, including A. 
phalloides spores, may be confused with leukocytes, eryth-
rocytes, epithelial cells, yeast cells, or fat droplets, which 
abound in the gastrointestinal tract (12).
Inappropriate conditions (eg, high humidity and tempera-
ture, exposure to light) and long storage of the studied 
material frequently hinder toxicological analysis and may 
lead to total breakdown of certain toxic substances. Exam-
ples of substances that are sensitive to storage conditions 
are psilocin and psilocybin, which break down readily in 
mushrooms stored at room temperature, as well as in 
aqueous solutions of low concentration (13,54,55). This 
is confirmed by the results of our research. Genet-
ic analysis classified three samples of dried mushrooms in 
which toxicological analysis failed to reveal the presence of 
psilocin within the species Psilocybe cubensis.
Our results show that molecular method is suitable for use 
in forensic genetic laboratories and that it can be imple-
mented using equipment and reagents employed in such 
laboratories. The advantage of this method over most oth-
er genetic methods used in toxic mushrooms analysis is 
that it can identify a very broad range of fungal species. 
However, in clinical poisonings, where rapid identification 
of the source of poisoning is paramount, this method can 
complement classical analytical methods, but cannot fully 
replace them.
Funding The research was funded by the Polish National Science Centre, 
project N N404 202439 “Application of sequence analysis of regions ITS1 
and ITS2 of nrDNA to species identification of poisonous and hallucinogen-
ic mushrooms for forensic purposes.”
ethical approval Not required.
declaration of authorship MK, AS, PM, and TK developed the concept of 
research and wrote the manuscript. AK, ZO, and SZ collected mycological 
material for analysis. MK and AS performed laboratory work and data pro-
cessing. Sporological analysis was carried out by ZO.
Competing interests All authors have completed the Unified Competing 
Interest Form at www.icmje.org/coi_disclosure.pdf (available on request 
from the corresponding author) and declare: support from Polish National 
Science Centre (ZO and SZ did not receive any support); no financial rela-
tionships with any organizations that might have an interest in the submit-
ted work in the previous three years; no other relationships or activities that 
could appear to have influenced the submitted work.
references
1 eren Sh, demirel Y, ugurlu S, Korkmaz i, Aktas C, Guven FM. 
Mushroom poisoning: retrospective analysis of 294 cases. Clinics 
(Sao Paulo). 2010;65:491-6. Medline:20535367 doi:10.1590/S1807-
59322010000500006
2 Kamińska B. The case of lethal intoxication afer consumption of 
Gyromitra esculenta [in Polish]. Problemy higieny. 1996;53:190-1.
3 Pawłowska J, Pawlak J, Kamiński A, hevelke P, Jankowska i, 
Teisseyre M, et al. Amanita phalloides poisoning as an indication 
for liver transplantation in three family members. Wiad lek. 
2006;59:131-4. Medline:16646310
4 Sienkiewicz e. Family poisoning by Macrolepiota rhacodes [in 
Polish]. Problemy higieny. 1996;53:192-4.
5 Strugała B, Tuszewska B, Wieland A. Mushroom poisonings in 
Poland in the period 1992-1994 [in Polish]. Problemy higieny. 
1996;53:185-9.
6 Pach J, editor. Basics of clinical toxicology [in Polish]. Kraków: Wyd. 
uniwersytetu Jagiellońskiego; 2009.
7 Maruyama T, Shirota O, Kawahara n, Yokoyama K, Makino Y, 
Goda Y. discrimination of psychoactive fungi (commonly called 
“magic mushrooms”) based on the dnA sequence of the internal 
transcribed spacer region [in Japanese]. Shokuhin eiseigaku Zasshi. 
39Kowalczyk et al: Genetic identification of mushrooms for clinical and forensic purposes
www.cmj.hr
2003;44:44-8. Medline:12749196 doi:10.3358/shokueishi.44.44
8 Stamets P. Psilocybin mushrooms of the world: an identification 
guide. Berkeley: Ten Speed Press; 1996.
9 Guzmán G, Allen JW, Gartz J. A worldwide geographical 
distribution of the neurotropic fungi, an analysis and discussion. 
Ann Mus civ rovereto Sez Arch St Sc nat. 1998;14:189-280.
10 Gartz J. new aspects of the occurrence, chemistry and cultivation 
of european hallucinogenic mushrooms. Ann Mus Civ rovereto. 
1992;8:107-24.
11 Janoszka J, rymkiewicz A, dobosz T. hallucinogenic mushrooms 
– Psilocybe. Part i. Characteristcs, consequences of consuming, 
identification [in Polish]. Arch Med Sadowej Kryminol. 
2005;55:215-9. Medline:16320771
12 Kapala M, nowacka A, Kicka M, rakowski M. Mushroom (fungi) 
poisonings investigated at the regional centre of acute poisoning, 
institute of Occupational Medicine and environmental health, 
Sosnowiec, Poland. Problems of Forensic Sciences. 2008;75:282-93.
13 Kała M. laboratory diagnostics in recognition, monitoring, course 
and prognosis of mushroom poisonings [in Polish]. Badania i 
diagnostyka. 2003;9:33-40.
14 Tsujikawa K, Kanamori T, iwata Y, Ohmae Y, Sugita r, inoue h, et 
al. Morphological and chemical analysis of magic mushrooms 
in Japan. Forensic Sci int. 2003;138:85-90. Medline:14642723 
doi:10.1016/j.forsciint.2003.08.009
15 Schmitt CJ, Weber AA, Maurer hh. immunoaffinity extraction 
of α-and β-amanitin of their sensitive detection in body fluids 
by atmospheric pressure ionization electrospray (APi-eS) lC-
MS. Proceedings of the 35th Meeting of TiAFT. Padua: Centre of 
Behavioural and Forensic Toxicology; 1997. p. 149-54.
16 Williams JG, Kubelik Ar, livak KJ, rafalski JA, Tingey SV. dnA 
polymorphisms amplified by arbitrary primers are useful as genetic 
markers. nucleic Acids res. 1990;18:6531-5. Medline:1979162 
doi:10.1093/nar/18.22.6531
17 linacre A, Cole M, lee JC. identifying the presence of ‘magic 
mushrooms’ by dnA profiling. Sci Justice. 2002;42:50-4. 
Medline:12012650 doi:10.1016/S1355-0306(02)71797-8
18 hebert Pd, Penton eh, Burns JM, Janzen dh, hallwachs W. Ten 
species in one: dnA barcoding reveals cryptic species in the 
neotropical skipper butterfly Astraptes fulgerator. Proc natl Acad 
Sci u S A. 2004;101:14812-7. Medline:15465915 doi:10.1073/
pnas.0406166101
19 lim BK. Barcoding life: demystifying the project that aims to 
classify the world’s 32 million species using only a short strand of 
dnA, ten rOM biologists report. royal Ontario Museum Magazine. 
2009;41:24-31.
20 White TJ, Bruns T, lee S, Taylor JW. Amplification and direct 
sequencing of fungal ribosomal rnA genes for phylogenetics. in: 
innis MA, Gelfand dh, Sninsky JJ, White TJ, editors. PCr protocols: a 
guide to methods and applications. new York, nY: Academic Press, 
inc; 1990. p. 315-22.
21 Gardes M, Bruns Td. iTS primers with enhanced specificity for 
basidiomycetes-application to the identification of mycorrhizae 
and rusts. Mol ecol. 1993;2:113-8. Medline:8180733 doi:10.1111/
j.1365-294X.1993.tb00005.x
22 lee JC, Cole M, linacre A. identification of members of the 
genera Panaeolus and Psilocybe by a dnA test. A preliminary 
test for hallucinogenic fungi. Forensic Sci int. 2000;112:123-33. 
Medline:10940597 doi:10.1016/S0379-0738(00)00181-X
23 nilsson rh, ryberg M, Kristiansson e, Abarenkov K, larsson Kh, 
Koljalg u. Taxonomic reliability of dnA sequences in public 
sequence databases: A fungal perspective. PloS One. 2006;1:e59. 
Medline:17183689 doi:10.1371/journal.pone.0000059
24 Sukrong S, Zhu S, ruangrungsi n, Phadungcharoen T, Palanuvej 
C, Komatsu K. Molecular analysis of the genus Mitragyna existing 
in Thailand based on rdnA iTS sequences and its application to 
identify a narcotic species: Mitragyna speciosa. Biol Pharm Bull. 
2007;30:1284-8. Medline:17603168 doi:10.1248/bpb.30.1284
25 uzuhashi S, Tojo M, Kobayashi S, Kakishima M. Pythium 
apinafurcum: its morphology, molecular phylogeny, and infectivity 
for plants. Mycoscience. 2009;50:281-90. doi:10.1007/S10267-009-
0486-0
26 Oda T, Tanaka C, Tsuda M. Molecular phylogeny and biogeography 
of the widely distributed Amanita species, A. muscaria and A. 
pantherina. Mycol res. 2004;108:885-96. Medline:15449593 
doi:10.1017/S0953756204000620
27 Schoch Cl, Seifert KA, huhndorf S, robert V, Spouge Jl, levesque 
CA, et al. nuclear ribosomal internal transcribed spacer (iTS) 
region as a universal dnA barcode marker for fungi. Proc natl 
Acad Sci u S A. 2012;109:6241-6. Medline:22454494 doi:10.1073/
pnas.1117018109
28 Seifert KA. integrating dnA barcoding into the mycological 
sciences. inoculum. 2008;59:2-6.
29 Seifert KA. Progress towards dnA barcoding of fungi. Mol ecol 
resour. 2009;9 Suppl s1:83-9. Medline:21564968 doi:10.1111/
j.1755-0998.2009.02635.x
30 Montpetit SA, Fitch iT, O’donnell PT. A simple automated 
instrument for dnA extraction in forensic casework. J Forensic Sci. 
2005;50:555-63. Medline:15932086 doi:10.1520/JFS2004181
31 nagy M, Otremba P, Krüger C, Bergner-Greiner S, Anders P, hensk 
B, et al. Optimization and validation of a fully automated silica-
coated magnetic beads purification technology in forensics. 
Forensic Sci int. 2005;152:13-22. Medline:15871915 doi:10.1016/j.
forsciint.2005.02.027
32 Anslinger K, Bayer B, rolf B, Keil W, eisenmenger W. Application 
of the Biorobot eZ1 in a forensic laboratory. leg Med 
(Tokyo). 2005;7:164-8. Medline:15847824 doi:10.1016/j.
legalmed.2005.01.002
33 Parys-Proszek A, Branicki W, Wolańska-nowak P, Kupiec T. 
Application of Biorobot M48 to forensic dnA extraction. Forensic 
Sci int Genet. 2008;1:58-9. doi:10.1016/j.fsigss.2007.10.066
FORENSIC SCIENCE 40 Croat Med J. 2015;56:32-40
www.cmj.hr
34 larkin MA, Blackshields G, Brown nP, Chenna r, McGettigan 
PA, McWilliam h, et al. Clustal W and clustal X version 2.0. 
Bioinformatics. 2007;23:2947-8. Medline:17846036 doi:10.1093/
bioinformatics/btm404
35 hall TA. Bioedit: a user-friendly biological sequence alignment 
editor and analysis program for Windows 95/98/nT. nucleic Acids 
Symp Ser. 1999;41:95-8.
36 Baser Sequence Assembler dnA. v3.x (2012), heracle BioSoft Srl 
romania. Available from: http://www.dnaBaser.com. Accessed: 
January 28, 2015.
37 Altschul SF, Gish W, Miller W, Myers eW, lipman dJ. Basic 
local alignment search tool. J Mol Biol. 1990;215:403-10. 
Medline:2231712 doi:10.1016/S0022-2836(05)80360-2
38 Brock PM, doring h, Bidartondo Mi. how to know unknown 
fungi: The role of a herbarium. new Phytol. 2009;181:719-24. 
Medline:19076294 doi:10.1111/j.1469-8137.2008.02703.x
39 Statzell-Tallman A, Belloch C, Fell JW. Kwoniella mangroviensis gen. 
nov., sp. nov. (Tremellales, Basidiomycota), a teleomorphic yeast 
from mangrove habitats in the Florida everglades and Bahamas. 
FeMS Yeast res. 2008;8:103-13. Medline:17961172 doi:10.1111/
j.1567-1364.2007.00314.x
40 Chen r, Jiang YM, Wei SC, Wang QM. Kwoniella shandongensis 
sp. nov., a basidiomycetous yeast isolated from soil and bark 
from an apple orchard. int J Syst evol Microbiol. 2012;62:2774-7. 
Medline:22447698 doi:10.1099/ijs.0.039172-0
41 Sun S, Metin B, Findley K, Fonseca A, heitman J. Validation of 
Kwoniella heveanensis, teleomorph of the basidiomycetous 
yeast Cryptococcus heveanensis. Mycotaxon. 2011;116:227-9. 
doi:10.5248/116.227
42 Findley K, rodriguez-Carres M, Metin B, Kroiss J, Fonseca A, Vilgalys 
r, et al. Phylogeny and phenotypic characterization of pathogenic 
Cryptococcus species and closely related saprobic taxa in the 
Tremellales. eukaryot Cell. 2009;8:353-61. Medline:19151324 
doi:10.1128/eC.00373-08
43 Guerreiro MA, Springer dJ, rodrigues JA, rusche ln, Findley 
K, heitman J, et al. Molecular and genetic evidence for a 
tetrapolar mating system in the basidiomycetous yeast Kwoniella 
mangrovensis and two novel sibling species. eukaryot Cell. 
2013;12:746-60. Medline:23524993 doi:10.1128/eC.00065-13
44 Adamczyk A, Sadakierska-Chudy A, Janoszka J, rymkiewicz 
A, dobosz T. hallucinogenic mushrooms – Psilocybe. Part ii. 
identification of Psilocybe semilanceata using PCr technique 
[in Polish]. Arch Med Sadowej Kryminol. 2007;57:285-8. 
Medline:17907620
45 harper KA, Smart Cd, Michael davis r. development of a dnA- 
Based macroarray for the detection and identification of Amanita 
species. J Forensic Sci. 2011;56:1003-9. Medline:21392001 
doi:10.1111/j.1556-4029.2011.01739.x
46 Kang S, Mansfield MA, Park B, Geiser dM, ivors Kl, Coffey Md, 
et al. The promise and pitfalls of sequence-based identification 
of plant-pathogenic fungi and oomycetes. Phytopathology. 
2010;100:732-7. Medline:20626276 doi:10.1094/PhYTO-100-8-
0732
47 Bidartondo Mi. Preserving accuracy in GenBank. 
Science. 2008;319:1616. Medline:18356505 doi:10.1126/
science.319.5870.1616a
48 Beug MW, Bigwood J. Psilocybin and psilocin levels in 
twenty species from seven genera of wild mushrooms in the 
Pacific northwest, u.S.A. J ethnopharmacol. 1982;5:271-85. 
Medline:7201053 doi:10.1016/0378-8741(82)90013-7
49 Kiss l. limits of nuclear ribosomal dnA internal transcribed 
spacer (iTS) sequences as species barcodes for fungi. Proc natl 
Acad Sci u S A. 2012;109:e1811. Medline:22715287 doi:10.1073/
pnas.1207143109
50 Froslev TG, Matheny PB, hibbett dS. lower level relationships in 
the mushroom genus Cortinarius (Basidiomycota, Agaricales): A 
comparison of rPB1, rPB2, and iTS phylogenies. Mol Phylogenet 
evol. 2005;37:602-18. Medline:16085431 doi:10.1016/j.
ympev.2005.06.016
51 nugent KG, Saville BJ. Forensic analysis of hallucinogenic fungi: 
A dnA-based approach. Forensic Sci int. 2004;140:147-57. 
Medline:15036436 doi:10.1016/j.forsciint.2003.11.022
52 Kallifatidis B, Borovička J, Stránská J, drábek J, Mills dK. Fluorescent 
random Amplified Microsatellites (F-rAMS) analysis of mushrooms 
as a forensic investigative tool. Forensic Sci int Genet. 2014;9:25-32. 
Medline:24528576 doi:10.1016/j.fsigen.2013.10.009
53 hahn C, raidl S, Beenken l. Can Amanita muscaria and Amanita 
caesarea be distinguished basing on herbarium material? 
Comparison of morphological-anatomical and genetic methods [in 
German]. Zeitschrift fur Mykologie. 2000;66:173-80.
54 Beug MW, Bigwood J. Quantitative analysis of psilocybin 
and psilocin in Psilicybe baeocystis (Singer and Smith) by 
high-performance liquid chromatography and by thin-
layer chromatography. J Chromatogr A. 1981;207:379-85. 
Medline:7194879 doi:10.1016/S0021-9673(00)88741-5
55 Andersson C, Kristinsson J, Gry J. Occurrence and use of 
hallucinogenic mushrooms containing psilocybin alkaloids. 
Copenhagen: nordic Council of Ministers; 2009.
